About Life Sciences Scotland
The Life Sciences Scotland Industry Leadership Group (LSS ILG) brings together industry, academia, enterprise agencies and government strategy teams. Their remit is to develop, drive and deliver the Life Sciences strategy in Scotland. By developing an environment where ingenuity and innovation can create jobs and wealth for Scotland, they aim to benefit the global community.
It fosters support and discussion between key players in the Life Sciences sector and those responsible for government policy-making to ensure Scotland has the best possible environment for fledgling technologies and established players.
The LSS ILG is co-chaired by Dave Tudor, Managing Director of the CPI’s Medicines Manufacturing Innovation Centre and Ivan McKee MSP, Minister for Trade, Investment and Innovation. The LSS ILG consists of senior representatives from stakeholders across the spectrum of the Life Sciences community: CEOs and Directors from pharmaceutical, biotechnology, medical devices and diagnostics companies; research organisations and academic institutions; Scottish Enterprise, Highlands and Islands Enterprise, the Scottish Government and Scotland’s National Health Service.
The LSS-ILG has focused on tackling key issues important to the sector and industry. Theme subgroups across Business Environment, Innovation and Commercialisation, Sustainable Production and Internationalisation with additional representation from colleagues across the sector have come together to address these challenges.
In light of the life sciences sector’s remarkable response to the Covid-19 pandemic, the ILG have identified key priorities within the strategy that aim to ensure patients have access to new and existing treatments, products and services and that the sector continues to grow.
Find out more about the Scottish Life Sciences Covid-19 Strategic Response Plan and, to get involved, contact ILG@scotent.co.uk